According to Evoke Pharma 's latest financial reports the company's current earnings (TTM) are -$7.3 M. an increase over its 2022 earnings that were of -$7.73 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$7.3 M | -5.59% |
2022 | -$7.73 M | -3.9% |
2021 | -$8.04 M | -38.37% |
2020 | -$13.05 M | 82.75% |
2019 | -$7.14 M | -10.96% |
2018 | -$8.02 M | -28.64% |
2017 | -$11.24 M | 6.51% |
2016 | -$10.55 M | -10.8% |
2015 | -$11.83 M | -10.03% |
2014 | -$13.14 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ANI Pharmaceuticals ANIP | $19.87 M | -372.51% | ๐บ๐ธ USA |
Amphastar Pharmaceuticals AMPH | $0.19 B | -2,822.29% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | -$23.25 M | 218.71% | ๐บ๐ธ USA |
Ironwood Pharmaceuticals
IRWD | -$0.95 B | 12,900.98% | ๐บ๐ธ USA |